68. Impact of neurofeedback in patients with epilepsy

Bakhtadze, S; Janelidze, Marina; Khachapuridze, N

doi:10.1016/j.yebeh.2010.01.093

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Numerous excellent reviews, metanalyses, and commentaries are available documenting the benefits of NFB for seizures/epilepsy (Bakhtadze et al, 2010; Duffy, 2000; Egner & Sterman, 2006; Kirlangic, 2005; Marzbani et al, 2016; Mayer & Arns, 2016; Nagai et al, 2019; Nigro, 2019; Omejc et al, 2019; Sterman, 2010a, 2010b; Tan et al, 2009, 2011).…”

Section: Nfb For Seizures/epilepsy—current Evidencementioning

confidence: 99%

Biofeedback and Health Evidence-Based Biofeedback and Neurofeedback for People with Epilepsy and Seiz

Turner¹

2022

Policy Insights from the Behavioral and Brain Sciences

View full text Add to dashboard Cite

Epilepsy is the fourth most common neurological disorder worldwide despite many anti-seizure medications. Biofeedback (BFB) and neurofeedback (NFB) have shown significant promise since the 1960s to improve seizure control, abnormalities in electroencephalography (EEG) and quantitative-EEG, and quality of life. Epilepsy is a disease of brain networks and BFB/NFB is a non-invasive, brain-centered, low-risk, low-cost, and reliable treatment for people with seizures/epilepsy and especially since standard seizure medications and epilepsy surgery often do not result in complete seizure control. Neuroscience healthcare clinician experience and a 60-year literature foundation show that BFB/NFB to improve brain dysregulation and abnormal network dynamics are known to be at the root of seizures/epilepsy. BFB/NFB trains individuals to self-regulate brain activity through real-time performance feedback. An exhaustive literature review for NFB/BFB and seizures/epilepsy (1960s–present) yielded 150 articles documenting improvements in seizures and EEG/QEEG abnormalities. Clinicians, insurers, and the public should support BFB/NFB as a first-line intervention for seizures/epilepsy.

show abstract